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Abstract
Diet-induced obesity (DIO) in rodents is characterized by impaired activation of signal-transducer and activator of
transcription 3 (STAT3) by leptin receptors (LepRb) within the hypothalamic arcuate nucleus. This signaling defect likely
plays an important role in development of DIO. However, the neuro-chemical identity of the leptin-STAT3 resistant arcuate
neurons has not been determined and the underlying mechanisms responsible for development of cellular leptin resistance
remain unclear. To investigate this, we first measured arcuate gene expression of known key signaling components of the
LepRb signaling pathway and tested whether specifically the critical arcuate pro-opiomelanocortin (POMC) neurons are
resistant to LepRb-STAT3 signaling in mice given a high-fat-diet (HFD) compared to mice provided a low-fat control diet
(LFD). We found that leptin-dependent STAT3 phosphorylation was decreased within POMC neurons of HFD mice. In
addition, Leprb mRNA and suppressor of cytokine signaling 3 (Socs3) mRNA were elevated in the arcuate of HFD mice. To
investigate whether increased LepRb expression per se in POMC neurons can influence development of DIO and Socs3
expression, we created mice that over-express LepRb selectively in POMC neurons (POMC-LepRb). No differences in body
weight, fat mass or food intake were found between LFD POMC-LepRb mice and LFD controls. Surprisingly, body weight, fat
mass and caloric intake of HFD POMC-LepRb mice was markedly higher than HFD control mice. In addition, arcuate Socs3
mRNA was increased in HFD POMC-LepRb mice compared to HFD controls. These data show that specifically POMC neurons
of DIO mice are resistant to STAT3 activation by leptin, indicating that those cells might play a role in development of DIO.
Furthermore, over-expression of LepRb selectively in POMC neurons increases susceptibility to the development of DIO. We
propose a model where over-reactivity of the leptin-LepRb signaling system in arcuate neurons may play causal a role in
development of diet-induced obesity.
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Introduction
Diet-induced obesity (DIO) in rodents is a principal model of
human obesity and results from over-consumption of a diet rich in
fat (high-fat diet (HFD)). DIO mice display increased caloric
intake, body weight and adiposity compared to mice maintained
on a low-fat diet (LFD). Leptin is a hormone produced by adipose
tissue and normally acts in the central nervous system to inhibit
food intake, and reduce fat mass and body weight [1]. However,
despite high circulating leptin levels, DIO animals and obese
humans are hyperphagic and have increased adiposity. In
addition, the anorexigenic and body-weight reducing effects of
exogenous leptin are blunted. This is generally termed leptin
resistant obesity [2]. The mechanism(s) whereby a HFD causes
leptin resistance and obesity however remain unclear. Elucidation
of these issues is important for our understanding of central
processes that leads to obesity.
Leptin normally acts on neurons in the hypothalamus and in
extra-hypothalamic brain-regions [3,4]. In particular, neurons
within the arcuate nucleus of the hypothalamus (ARC) play a key
role in leptin’s metabolic actions [2,5,6,7,8]. Significant attention
and importance has been given to pro-opiomelanocortin (POMC)
neurons that express functional LepRb [3,9]. POMC neurons
produce several neuropeptides, including the anorexigenic a-
melanocyte-stimulating hormone (a-MSH) [10]. a-MSH is a
ligand for melanocortin–receptors (MC-Rs) and is a potent
inhibitor of food intake [11]. A second population of leptin-
responsive neurons also located in the ARC co-expresses agouti-
related peptide (AgRP) and neuropeptide Y (NPY) [12]. AgRP
stimulates appetite by acting as an antagonist of a-MSH at MC-Rs
[13]. Together, the POMC-, AgRP- and MC3/4R-expressing
neurons comprise the central melanocortin system [10]. Deletion
of LepRb specifically from POMC and AgRP neurons in mice
lead to mild obesity [14,15]. Conversely, Cre-mediated re-
expression of LepRb selectively in POMC neurons of the Lepr
db/db
mice reduces caloric intake and body weight [16]. Direct leptin
action via POMC and AgRP neurons is therefore required for
normal body weight homeostasis, although it is also clear that
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e30485additional nuclei/neurons targets are needed to mediate the full
complement of leptin actions.
The leptin receptor (LepR) belongs to the cytokine receptor
superfamily [2] and signals via a number of downstream pathways,
including the Janus kinase 2 (JAK2) and signal-transducer and
activator of transcription 3 (STAT3) pathway [17,18]. Phosphor-
ylated STAT3 (P-STAT3) regulates gene expression, including
stimulation of the pomc gene in POMC neurons [3]. Suppressor of
cytokine signaling 3 (SOCS3) is a critical negative-feedback
regulator of LepRb signaling and its expression is increased
transcriptionally by P-STAT3 binding to the Socs3 promoter in
LepRb positive neurons, including POMC cells [14,19,20,21,22,23].
In addition, protein tyrosine phosphatase 1B (PTP1B or PTPN1) and
the related T-cell-related protein tyrosine phosphatase, TC-PTP/
PTPN2, are direct cellular inhibitors of JAK2 and STAT3, respec-
tively [24,25,26,27].
DIO rodents are characterized by hyper-leptinemia in con-
junction with elevated arcuate Socs3 gene expression and impaired
leptin-dependent activation of P-STAT3 within ARC neurons
[28,29,30,31,32,33,34]. This, together with metabolic data from
mice with selective over-expression or deletion of SOCS3 from
hypothalamic neurons [35,36] has promoted the idea that SOCS3
is a key mediator of neuronal leptin resistance, although the
mechanism whereby a HFD increases SOCS3 expression is yet
unclear. Studies also support possible roles for PTP1B and TC-
PTP in causing neuronal leptin resistance in the hypothalamus of
DIO mice, since altered levels/activity of those proteins, like
SOCS3, are also expected to affect leptin-induced STAT3
phosphorylation [24,25,37,38,39,40]. Similar to SOCS3, the
mechanism whereby the HFD may up-regulate hypothalamic
PTP1B and TC-PTP expression remains undetermined, but might
involve inflammatory processes or hyperleptinemia [41,42,43].
Additional unresolved critical questions include the neuro-
chemical identity of the P-STAT3-resistant hypothalamic neurons
of DIO rodents, since those cells likely play principal roles in
development and/or maintenance of obesity.
Some studies have reported increased Lepr mRNA levels in the
hypothalamus of DIO rodents [29,44,45]. This increase may
reflect a mechanism that serves to counteract leptin resistance.
Alternatively and more interestingly, increased leptin receptor
expression might directly play a causal role in the development of
leptin resistance. Since LepRb signaling increases Socs3 expression,
it is at least plausible that hyperleptinemia might increase SOCS3
protein amounts in key target neurons eventually resulting in long-
term neuronal leptin resistance. Indeed, we have earlier reported
that acute leptin signaling in cell lines induces long-term SOCS3
expression and a parallel prolonged impairment of STAT3
activation by leptin [46]. In further support of such a model of
over-reactivity of the leptin-LepRb system in causing obesity, it has
been reported that leptin itself (hyperleptinemia) is required for the
development of neuronal leptin resistance (impaired STAT3
phosphorylation in response to exogenous leptin) in the ARC of
HFD mice [47]. Moreover, mice that chronically over-express
leptin paradoxically accumulates fat mass with age and exhibit
increased susceptibility to HFD-induced obesity [48,49]. The
effect of hypothalamic over-expression of LepRb on the
development of DIO has not been investigated.
We here demonstrate that specifically arcuate POMC neurons
of DIO mice are resistant to LepRb-STAT3 signaling, suggesting
an important role of those particular neurons in the development
and/or maintenance of diet-induced-obesity. Consistent with some
previous reports, we also show increased Socs3 mRNA and Leprb
mRNA in the arcuate nucleus of DIO mice. Secondly, we found
that genetically-driven over-expression of LepRb selectively in
arcuate POMC neurons is sufficient to accelerate development of
obesity in HFD mice. Based on these data, we propose a model
where over-reactivity of the leptin-LepRb signaling system in
hypothalamic neurons, including POMC neurons, may play a role
in causing leptin resistance and obesity in high-fat fed mice.
Results
Diet-induced obesity and cellular leptin resistance in
C57Bl/6J mice
To investigate cell types, genes and mechanisms involved in the
development of ARC leptin-resistance in diet-induced obesity
(DIO), groups of obesity-prone C57Bl/6J mice were given ad
libitum access to a high-fat diet (HFD) or low fat diet (LFD) for 3, 7
and 11 weeks. As expected, after 3 weeks, the HFD group had
increased body weight (BW) and cumulative caloric intake
compared to the animals maintained of a LFD (Fig. 1). Serum
leptin levels were not measured, but hyperleptinemia in DIO mice
is well documented in previous studies [22,30,31,50]. Differences
in BW and food intake between HFD and LFD groups increased
further with longer periods of time on the respective diets.
To identify genes that might be involved in development of
DIO and ARC leptin resistance, mRNA was isolated from ARC
tissue of 3-, 7- and 11- week HFD and LFD mice, and subjected to
real-time RT-PCR. While most of these genes have been
measured earlier, the results differ between studies indicating that
further investigations are needed. In addition, few studies have
measured the expression at different stages during the develop-
ment of DIO. We found that Leprb mRNA was increased (,75%)
in 11-week DIO mice while Socs3 mRNA was increased (,30%) at
7 weeks and further increased (,75%) after 11 weeks on the HFD
(Fig. 2A). Small increases (,20%) in mRNA levels of the JAK2
phosphatase, PTP1B/PTPN1, and of the PTP1B-related STAT3
phosphatase, TC-PTP/PTPN2, were found after 11 weeks of
HFD. Steady-state mRNA levels of Socs1 and Jak2 were also not
different between LFD and HFD groups. Similarly, Npy and Agrp
levels were not different between groups, although Pomc mRNA
indicated an increase by ,35% in 11-week DIO mice, although
not reaching statistical significance (Fig. 2B).
We have previously reported that the number of P-STAT3-
immunoreactive (IR) neurons is reduced in the ARC of leptin-
treated DIO C57Bl/6J mice (4- and 16-weeks of HFD) [31],
demonstrating cellular/neuronal leptin resistance. To extend those
analyses, we here both counted and quantified P-STAT3-IR in
ARC neurons in new groups of C57Bl/6J mice given HFD or
LFD for 10 weeks. In contrast to previous studies, leptin was only
injected at a half-maximal dose (for activation of STAT3)(0.6 mg/
kg, i.p., 30 min) according to El-Haschimi et al. [26] to enhance
the ability to detect potential differences. As shown in Fig. 3A, P-
STAT3 immunoreactivity was indeed reduced in the ARC of DIO
mice and we found that the total number of P-STAT3-IR cells was
reduced (,20%) compared to LFD controls (p=0.013) (Fig. 3B),
consistent with earlier data [27,30]. Furthermore, we show that
quantification of P-STAT3 immunoreactivity in all ARC neurons
combined was reduced by ,40% (p=0.036) in DIO mice
(Fig. 3C). Thus, both the total number of leptin-responsive ARC
neurons and the signaling responsiveness within individual P-
STAT3 positive cells are markedly reduced in leptin-treated DIO
mice.
A change in the number of key leptin-responsive neurons would
likely affect whole-body leptin action and therefore represents on
possible mechanism causing leptin-resistant DIO. We therefore
assessed the number of POMC neurons in lean and obese mice. In
4-week LFD C57Bl/6J mice (N=4), we found by in situ
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entire hypothalamus (Fig. 4A). In HFD mice (N=4), the number
of POMC neurons as determined by ISH was slightly increased by
125% to 41006260, although this difference was not statistically
significant (p=0.063). The number of POMC neurons as
determined by immunohistochemistry (Fig. 4B) also indicated a
modest increase (,175%; p=0.095) in 10 wk HFD mice (Fig. 4C).
POMC polypeptide levels per POMC neuron (soma) were not
different between the two groups (Fig. 4D). To specifically assess
cellular leptin sensitivity within POMC neurons of DIO mice, we
counted POMC neurons that were positive for P-STAT3 (nuclear)
bydoubleP-STAT3/b-Endorphinimmunohistochemistry(Fig.5A),
according to methods described earlier [16]. As shown in Fig. 5B,
the percentage of leptin-responsive (P-STAT3-IR) POMC neurons
(b-Endorphin-IR) was reduced from 64% in lean LFD mice to 50%
in obese HFD mice (p=0.024). More strikingly, quantification of
the average level of STAT3 phosphorylation (nuclear) within
individual POMC neurons showed a reduction by 50% in DIO
mice (p=0.036) (Fig. 5C). Combined, these data suggest that DIO
mice are characterized by increased ARC expression of Socs3 and
Leprb mRNA (Fig. 2), and by a marked cellular resistance of arcuate
neurons (Fig. 3), including specifically POMC neurons (Fig. 5), to
activate intracellular LepRb signaling in response to exogenous
leptin.
Diet-induced obesity in C57Bl/6J mice over-expressing
leptin receptors in POMC neurons
To mechanistically pursue the above findings and directly
investigate the possibility that increased LepRb expression in arcuate
POMC neurons may play a role in the development of
hypothalamic leptin resistance in DIO mice, we tested suscepti-
bility to develop DIO in transgenic mice that over-express HA-
tagged LepRb specifically in POMC neurons (POMC-LepRb
mice). We have previously created POMC-LepRb mice and
demonstrated that HA-LepRb is functional and is selectively
expressed in POMC neurons [16]. We here first backcrossed the
POMC-LepRb mice from a mixed genetic background to the
C57Bl/6J background for better comparison to the above data
from C57Bl/6J DIO mice (Fig. 1, 2, 3, 4, 5), since it is well known
that genetic background greatly affects sensitivity to high-fat
feeding. C57Bl/6J POMC-LepRb mice and littermate controls
were then given ad lib access to the HFD or LFD for 19 weeks. As
shown in Fig. 6A, and as expected, C57Bl/6J control mice on the
HFD gained weight faster as compared to C57Bl/6J mice
maintained on the LFD. Furthermore, the body-weight curve of
POMC-LepRb mice given the LFD was not different from that of
littermate controls on the same LFD. This is consistent with our
previous data showing that the BW of POMC-LepRb mice (both
on a pure FVB genetic background and on a mixed FVB/
C57Bl6J/KsJ background) are not different from the BW of
littermate controls on a chow diet [16]. Interestingly however,
when C57Bl/6J POMC-LepRb mice were given the HFD, BW
increased markedly faster relative to C57Bl/6J control littermates
on the same diet (Fig. 6A). The increased BW of HFD POMC-
LepRb animals correlated with increased cumulative caloric intake
(Fig. 6B and 6C), and with increased total fat mass and weights of
select adipose depots (Figs. 7B–D). Lean mass (Fig. 7A) and blood
glucose concentrations (Fig. 8) did not differ between groups.
Figure 1. Diet-induced obesity in C57Bl/6J mice. A–C. Shown are body-weight curves of C57Bl/6J mice given HF or LF diets for 3, 7 and 11
weeks, respectively. D–F. Shown is cumulative food intake after 3, 7 and 11 weeks of diets, respectively. *=p,0.05; **=p,0.01; #=p,0.001. N=23–
25 animals per group. Data are means +/2 SEM.
doi:10.1371/journal.pone.0030485.g001
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that Socs3 expression was increased (,60%, p,0.01) relative to
HFD controls, while mRNA levels of Ptp1b/Ptpn1 and Tc-ptp/
Ptpn2 were not altered (Figs. 9A–C). Hypothalamic NPY or AgRP
neuropeptide levels were also not different between the two
groups. a-MSH neuropeptide levels in the hypothalamus of HFD
POMC-LepRb mice were not statistically different (p=0.16) from
that of HFD controls (Figs. 9D–F).
To assess whole-body leptin-sensitivity, POMC-LepRb and
control mice were injected with leptin or vehicle (PBS) before and
after 5 weeks of HFD. This dose of leptin (5 mg/kg) did not
significantly affect 1–24 hour food intake in LFD or HFD controls
or in POMC-LepRb mice on either diet (Figs. 10A and 10B),
although there was a trend towards lower intake at all time-points
in POMC-LepRb mice on the LFD, but not on the HFD. Leptin
significantly reduced 24-hour BW-gain in both LFD control and
LFD POMC-LepRb mice (Fig. 10C). Leptin did not affect food
intake or BW-gain in any of the two groups of mice on the HFD
(Fig. 10D), indicative of leptin resistance. To assess responsiveness
to anorexigenic signals immediately down-stream of POMC
neurons, effects of MTII, a stable a-MSH analogue and agonist
of the central melanocortin receptors, on BW and energy intake
were measured. As shown in Fig. 11A, MTII reduced intake (2–
4 hours) similarly in both control and POMC-LepRb mice given a
LFD. MTII’s food-inhibitory effect was not significant in either
group on the HFD. However, MTII inhibited BW-gain in both
groups given either the LDF or HFD (Figs. 11C and 11D),
altogether suggesting lack of leptin resistance in neuro-circuitries
(the melanocortin pathway) located immediately downstream of
POMC neurons of DIO mice.
Discussion
There are two primary findings in this report. First, we show
that POMC neurons of DIO mice are resistant to activation of
STAT3 phosphorylation by leptin. Secondly, we find that over-
expression of LepRb selectively in hypothalamic POMC neurons
is sufficient to accelerate development of diet-induced obesity. We
propose a model where over-reactivity of the leptin-LepRb
signaling system in POMC neurons may play a role in
Figure 2. Arcuate nucleus gene-expression in LFD and HFD C57Bl/6J mice. Shown are real-time RT-PCR results from arcuate tissues isolated
from LFD and HFD C57Bl/6J mice (Fig. 1). Data for HFD are represented as % change from the LFD control group from each time-point (i.e. 3, 7 or 11
weeks of diets). The average expression level in LFD is normalized to 0% at each time-point. *=p,0.05; **=p,0.01. N=22–24 mice per group. Data
are means +/2 SEM.
doi:10.1371/journal.pone.0030485.g002
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diet fed mice.
Several groups, including our own, have previously reported
impaired activation by leptin of STAT3 DNA-binding activity and
of STAT3 phosphorylation within the hypothalamus, particularly
the arcuate nucleus, of DIO mice [30,31,47,50,51]. However the
neuro-chemical nature of those P-STAT3 resistant cells has not
been reported. Our identification of arcuate POMC neurons of
DIO mice as being resistant to STAT3 phosphorylation by leptin
at least opens the possibility that those specific cells might play a
causal role in the development of hyperphagia and diet-induced
obesity. Since the extent of impaired neuronal P-STAT3
activation is observed throughout the arcuate of DIO mice, it is
likely that the many if not all of the remaining LepRb-expressing
neurons in this nucleus are also leptin resistant, including the
AgRP/NPY neurons. This is consistent with the earlier finding
that both POMC and AgRP/NPY neurons from DIO mice show
impaired neuropeptide release in response to leptin [51].
We further observed that arcuate Leprb mRNA is increased in
diet-induced obese mice after 11 weeks of HFD. Some studies
[29,44,45], but not all [31,51,52,53], have similarly reported an
increase in Lepr mRNA in the ARC of DIO mice. The reason for
the divergent results is unclear but is likely due to various lengths
of the feeding studies, use of different rodent strains/species or
different compositions of diets, and/or whether whole hypotha-
lamic tissue or only arcuate tissue was analyzed. We have not been
able to detect LepRb by Western blotting of hypothalamic tissues
in order to complement the mRNA data. This is likely due to
insufficient expression of the receptor, since we have previously
shown that we are able to detect LepRb in protein lysates from
transfected cells [17]. The mechanism whereby HFD might
increase hypothalamic Leprb gene-expression is unknown. Possi-
bilities include that leptin itself (hyperleptinemia) via LepRb
signaling directly or alternatively, that a component in the HFD
indirectly stimulates hypothalamic Leprb mRNA. The increase in
arcuate Leprb mRNA in DIO mice could indicate the presence of
counter-regulatory mechanism. Alternatively, it is possible that up-
regulation of leptin receptor expression is a primary event that
may cause cellular leptin resistance through chronic over-
stimulation the leptin-LepRb signaling system. In support of this
possibility, we show here that forced over-expression of LepRb in
POMC neurons is sufficient to accelerate weight gain in HFD
mice. In addition, hyperleptinemia itself is reported to be required
for development of hypothalamic leptin-resistant STAT3 signaling
in DIO mice [47].
The result that over-expression of LepRb in POMC neurons
increases body weight in HFD mice is initially surprising,
considering the well known anti-obesity effect of the leptin-LepRb
Figure 3. Arcuate neuronal leptin-sensitivity in LFD and HFD C57Bl/6J mice. C57Bl/6J mice were given diets for 10 weeks and injected with
leptin (0.6 mg/kg, 30 minutes). A. Shown are representative microphoto images of P-STAT3 immunohistochemistry in the ARC of leptin-treated LFD
and HFD mice. Matched representative coronal sections from the rostral, medial and caudal mediobasal hypothalamus are presented. B. Number of P-
STAT3-immunoreactive (IR) ARC neurons in LFD and HFD mice. N=5 sections per animal, and N=3 mice per group. Counts are from one hemisphere
in each section. C. Shown is quantification of the combined immunoreactivity (P-STAT3 IR) of all ARC P-STAT3 positive neurons. N=5 sections per
animal, and N=3 mice per group. Analyses are done on one hemisphere from each section. *=p,0.05. Arc=hypothalamic ARC nucleus. Data are
means +/2 SEM.
doi:10.1371/journal.pone.0030485.g003
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POMC neurons of Lepr
db/db mice reduces body weight [16]. This
apparent paradox may be explained by the fact that total LepRb
expression within individual POMC neurons is likely higher in our
POMC-LepRb mice of current study because of the presence of
both transgenically-derived LepRb and of endogenous LepRb. In
addition, the HFD may further increase endogenous Leprb mRNA
in POMC-LepRb mice as discussed above. In contrast, POMC-
LepRb-Lepr
db/db mice only express transgenically-derived LepRb
proteins (which we have previously shown to be expressed at a
level that is similar to that of endogenous LepRb in POMC
neurons of normal mice [16]). In addition, in the earlier study we
did not challenge POMC-LepRb-Lepr
db/db mice with a HFD. If
POMC-LepRb-Lepr
db/db mice do not accelerate weight gain when
given a HFD, we would conclude that either the total LepRb
expression within POMC neurons level in too low, or alternative-
ly, that leptin signaling in other neurons in addition to POMC
neurons is required for development of DIO. These important
issues will be investigated in future studies.
On the high-fat diet,we found that the POMC-LepRb animals were
similarly resistant to exogenous leptin as compared to HFD control
mice. In contrast, POMC-LepRb mice on LFD and HDF were
similarly sensitive to MTII-induced body weight loss as compared to
control mice.These data combined at least suggest that the site of leptin
resistance in the HFD POMC-LepRb mice is at the level of the
POMC neurons themselves, and not in downstream pathways.
The exact mechanism whereby a HFD causes chronic up-
regulation of arcuate Socs3 expression in DIO mice is unclear. In
lean rodents, leptin acutely stimulates STAT3 phosphorylation
and Socs3 mRNA in POMC neurons [14,35,54]. Indeed, P-
STAT3 stimulates socs3 gene expression via direct binding to the
socs3 promoter [20,21]. SOCS3 proteins then act in a negative
feedback loop to attenuate leptin signaling [2,19]. In cell lines,
acute leptin signaling can induce long-lasting SOCS3 protein
expression and leptin resistance (i.e. impaired STAT3 activation)
[46]. In the ARC of normal DIO mice, Socs3 mRNA is chronically
elevated [31,51] and neurons are resistant to STAT3 activation by
leptin [31,50,51,55,56]. One possible mechanism explaining the
chronic increase in Socs3 and impaired leptin signaling is that the
HFD, either directly via components in the diet itself or indirectly
by increasing local or systemic levels of inflammatory cytokines,
stimulates arcuate Socs3 gene-expression [34,57,58,59,60]. Alter-
natively, hyperleptinemia itself may increase Socs3 expression to a
level that eventually inhibits LepRb-STAT3 signaling, similar to
what we have shown earlier in leptin-treated cell lines [46]. Our
current data are consistent with a model where the HFD increases
arcuate LepRb expression resulting in over-stimulation of LepRb
signaling pathways, ultimately leading to long-term elevation of
SOCS3 proteins levels and chronic down-regulation of LepRb
signaling. Indeed, mice that chronically over-express leptin
accumulate fat mass with age [48] and exhibit increased
susceptibility to diet-induced obesity [49].
Consistent with this model of over-stimulation of LepRb
signaling in POMC neurons leading to obesity, it has been
reported that forced over-expression of a constitutively active (CA)
form of STAT3 in POMC neurons is sufficient to cause obesity,
Figure 4. POMC polypeptide expression in LFD and HFD C57Bl/6J mice. A. Shown are matched representative images of POMC neurons as
detected in situ hybridization. Matched coronal sections from the rostral, medial and caudal mediobasal hypothalamus of a LFD mouse are presented.
B. Shown are matched representative images POMC neurons as detected by POMC immunohistochemistry in the mediobasal hypothalamus of LFD
and HFD mice. Matched coronal sections from the rostral, medial and caudal mediobasal hypothalamus are presented. C57Bl/6J mice were given
diets for 10 weeks and injected with leptin (0.6 mg/kg) 30 minutes before sacrifice. C. Number of POMC-immunoreactive neurons per LFD and HFD
mouse. N=2 mice per group. D. Shown is quantification of POMC immunoreactivity per POMC neuron. N=2 mice per group.
Tmt=Mammillothalamic tract; fx=fornix; DMH=Dorsomedial hypothalamic nucleus; VMH=Ventromedial hypothalamic nucleus. Data are means
+/2 SD.
doi:10.1371/journal.pone.0030485.g004
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animals have chronically elevated hypothalamic Socs3 mRNA,
presumably mediated by constitutively active STAT3-induced
Socs3 gene-expression in POMC neurons. It is therefore possible
that SOCS3 protein levels have reached an ‘‘obese threshold’’ in
POMC neurons in those mice, causing reduced LepRb-STAT3
signaling. The reason that our LepRb-POMC mice do not
develop obesity on a LFD (Fig. 6) or chow diet [16], in contrast to
the CA STAT3-POMC mice, may be explained by the lack of
elevated leptin levels; i.e. despite the forced increase of LepRb, the
circulating leptin concentration is not sufficient to activate STAT3
and to increase Socs3 expression to the threshold-level that causes
long-term cellular leptin-resistance. We propose that any mech-
anism that increases SOCS3 protein expression beyond a certain
level in POMC neurons will cause long-term leptin resistance in
those cells and eventually to obesity. Consistent with this ‘‘SOCS3-
threshold’’ hypothesis, it was recently demonstrated that geneti-
cally-driven over-expression of SOCS3 in POMC neurons is
sufficient to cause obesity even in chow-fed mice [36]. In addition,
genetic deletion of Socs3 from POMC neurons attenuates the
development of DIO [35]. Importantly, since these POMC-
SOCS3 KO mice given a HFD still show an increase in body
weight and hyperleptinemia compared to LFD mice (albeit both
are attenuated compared to HFD control mice), it is clear that
additional mechanisms (e.g. elevated LepRb and/or SOCS3 (and/
or PTP1B and/or PTPN2) expression in other neurons (e.g.
AgRP)) also play important roles in the development of leptin
resistance and diet-induced obesity.
In conclusion, we show that POMC neurons of DIO mice are
resistant to STAT3 activation by leptin and that over-expression of
LepRb only in POMC neurons is sufficient to potentiate the
development of diet-induced obesity. We propose a model where
chronic over-stimulation of the leptin-LepRb signaling pathway in
arcuate neurons may play a role in development of arcuate leptin
resistance and diet-induced obesity, possibly via elevation of
SOCS3 expression.
Materials and Methods
Ethics Statement
Care of mice and animal procedures used in this study were
approved (protocol #011-2010) and performed according to
standards set by the Institutional Animal Care and Use Committee
(IACUC) at Beth Israel Deaconess Medical Center.
Animals and animal care
Male C57Bl/6J mice at 3–4 weeks of age were ordered from
Charles River Laboratories (Boston, MA). Transgenic POMC-
LepRb mice on the C57Bl/6J background were created as
described below. Care of mice and animal procedures were
approved and performed according to standards set by the
Institutional Animal Care and Use Committee (IACUC) at Beth
Israel Deaconess Medical Center. Unless otherwise noted, mice
were housed at 22uC–24uC using a 14 hr light/10 hr dark cycle
with light on a 7 a.m. and chow food (Teklad F6 Rodent Diet 8664,
4.05 kcal/g, 3.3 kcal/g metabolizable energy, 12.5% kcal from fat,
Harlan Teklad, Madison, WI) and water provided ad libitum.
Diet-induced obesity
At 5-weeks of age, mice were placed on a low-fat diet (LFD)
(Research Diets 12329: 16% protein; 73% carbohydrate; 11% kcal
from fat) or a high-fat diet (HFD) (Research Diets 12331: 16%
protein; 26% carbohydrate; 58% kcal from fat, Research Diets,
New Brunswick, NJ). Body weight (BW) was measured once a
Figure 5. Leptin-dependent STAT3 phosphorylation in POMC neurons of LFD and HFD C57Bl/6J mice. A. Shown are representative
images of double immunohistochemistry for P-STAT3 (DAB) and b-Endorphin (green fluorescence) in the mediobasal hypothalamus of leptin-treated
LFD and HFD mice. C57Bl/6J mice were given diets for 16 weeks and injected with leptin 30 minutes before sacrifice. B. Percentage of P-STAT3
immunoreactive POMC (b-Endorphin) neurons per hypothalamus. One hemisphere of 9–11 matched hypothalamic brain sections was analyzed in
each animal. C. Shown is the total P-STAT3 immunoreactivity (P-STAT3 IR) in all POMC neurons. For B. and C. P-STAT3 was counted and quantified in
258624 POMC neurons from LFD mice (N=3) and in 289625 POMC neurons from HFD mice (N=4). VMH=Ventromedial hypothalamic nucleus;
DMH=Dorsomedial hypothalamic nucleus. *=p,0.05. Data are means +/2 SEM.
doi:10.1371/journal.pone.0030485.g005
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Fresh pellets of food were provided every 3 days to avoid
temperature-dependent spoilage of the HFD, and cages were
changed every time food weight was measured. Any residual bits
of food in the bedding were included in measurements.
Cumulative food intake data was obtained by adding all intake
measurements during the study.
Generation of C57Bl/6J POMC-LepRb mice
HA-LepRb STOP transgenic mice [16] were mated with wild-
type C57Bl/6J mice (Charles River Laboratories) for seven
generations. Pomc-Cre mice, also described earlier [14], were
kindly supplied by Dr. Bradford Lowell (BIDMC, Boston, MA)
and also mated with C57Bl/6J mice for at least seven generations.
The C57Bl/6J HA-LepRb STOP (heterozygous) mice were then
mated with C57Bl/6J Pomc-Cre (heterozygous) mice to generate
C57Bl/6J Pomc-Cre/HA-LepRb mice (POMC-LepRb) and control
littermates.
Blood composition
Tailvein blood was collected at 12:00 PM62 hr from mice
maintained on LFDs or HFDs. Mice were either ad libitum fed or
fasted for 24 hours. At 12 and 17 weeks of age, blood was assayed
for fed and fasted glucose levels, respectively (Fisher Scientific,
Morrison Plains, NJ).
Isolation of hypothalamic tissues by microdissection
Animals were euthanized by cervical dislocation and brains
were rapidly removed. Using a cooled mouse brain matrix with 1-
mm section dividers (ASI Instruments Inc., Warren, MI), one
Figure 6. Body weight and caloric intake of POMC-LepRb mice on HFD and LFD. A. Body-weight curves of C57Bl/6J control mice and
POMC-LepRb (C57Bl/6J) mice given HFD or LFD diets. B. Final average body weights after 19 weeks on diets. C. Cumulative food intake during the 19
weeks on diets. *=p,0.05; **=p,0.01; #=p,0.001; ns=Not significant. All mice are littermates. N=8–9 POMC-LepRb and N=20–21 control
animals per group. Data are means +/2 SEM.
doi:10.1371/journal.pone.0030485.g006
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D. Perirenal fat mass. All animals are littermates. *=p,0.05; **=p,0.01. ns=Not significant. N=6–7 POMC-LepRb and N=15–16 control animals per
group. Data are means +/2 SEM.
doi:10.1371/journal.pone.0030485.g007
Figure 8. Serum glucose in POMC-LepRb mice on HFD and LFD. A. Ad libitum fed glucose levels. B. Overnight fasted glucose levels. Fed
glucose was measured at 12 weeks and fasted levels at 17 weeks on diets. ns=Not significant. N=8–9 POMC-LepRb and N=18–19 control mice per
group. Data are means +/2 SEM.
doi:10.1371/journal.pone.0030485.g008
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and right of the bisectional cut to produce two 1-mm-thick sagittal
sections left and right of the third ventricle. Landmarks including
the fornix, optic tracts and mammillary nuclei were used to dissect
reproducible pieces of the ARC-enriched regions, as described
earlier [31]. Two tissue pieces (one from each hemisphere) from
each animal were combined and snap-frozen in liquid nitrogen
and stored at 280uC until further use.
RNA extraction, cDNA synthesis and real-time PCR
Total RNA was isolated from ARC tissue blocks using RNA
STAT60 (Tel-Test, Friedenswood, TX). Five hundred nanograms of
total RNA was used for reverse transcription (RT-PCR kit;
Clonetech, Palo Alto, CA). Quantification was carried out by real-
timePCRusingtheStratageneMx3000Psystem.Thereal-timePCR
was performed according to the manufacturer’s instructions with
minor alterations. The primers (F and R) (Invitrogen, Carlsbad, CA)
and probes (P)(Biosearch Technologies, Novato, CA) were designed
withtheassistanceofPrimerExpresssoftwareasfollows:SOCS3F(59-
GCGGGCACCTTTCTTATCC-39), SOCS3R (59-TCCCCGAC
TGGGTCTTGAC-39) and SOCS3P [59- TCGGACCAGCGC-
CACTTCTTCAC-BHQ-1–39); CyclophilinF (59- GGTGGAGAG-
CACCAAGACAGA-39), CyclophilinR (59-GCCGGAGTCGA-
CAATGATG-39) and CyclophilinP (59-ATCCTTCAGTGGC
TTGTCCCGGCT-39). Primers/Probe sets for Pomc were: POMCF
(59-ACCTCACCACGGAGAGCA-39), POMCR (59-GCGAGAG
GTCGAGTTTGC-39)a n dP O M C P( 5 9-TGCTGGCTTGCAT
CCGGG-39); for Npy: NPYF (59-CTCCGCTCTGCGACACTAC-
39), NPYR (59-AATCAGTGTCTCAGGGCT-39)a n dN P Y P( 5 9-
CAATCTCATCACCAGACAG9-3); and for Agrp:A g R P F( 5 9-
GCGGAGGTGCTAGATCCA-39), AgRPR (59-AGGACTCGTG-
CAGCCTTA-39)a n dA g R P P( 5 9-CGAGTCTCGTTCTCCGCG-
39). Primers/Probe sets for Leprb Jak2, Socs1, Ptp1b and Tc-ptp were
purchased from Applied Biosystems (Foster City, CA). PCRs were
run in a volume of 25.0 mlu s i n g1 . 0ml cDNA. A standard curve was
generated from duplicate measurements of serial dilutions of ARC
cDNA.
Quantification of neuropeptides
Neuropeptides were extracted from whole hypothalamic tissues
and measured by enzyme immunoassay (EIA). The extraction and
purification of the peptides were performed as previously
Figure 9. Arcuate mRNA and hypothalamic neuropeptide levels in HFD POMC-LepRb mice. A–C. Arcuate SOCS3 mRNA, PTP1B mRNA and
TC-PTP mRNA in POMC-LepRb and control mice after 19 weeks of HFD. Each mRNA was normalized to cyclophilin mRNA in the same samples. N=6
POMC-LepRb and N=11 control mice. D-F. Whole hypothalamic a-MSH, NPY and AgRP neuropeptide levels in POMC-LepRb and control mice after 19
weeks of HF diet. a-MSH: N=6 POMC-LepRb and N=13 control mice. NPY and AgRP: N=3 POMC-LepRb and N=10 control mice. **=p,0.01. Data
are means +/2 SEM.
doi:10.1371/journal.pone.0030485.g009
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MSH, NPY, and AgRP (all in-house assays) [16]. The sensitivities
of the assays were 2, 8 and 9 pg per sample, respectively.
Leptin and MTII sensitivity
Mice were fasted overnight and given vehicle (PBS) or leptin
(5 mg/kg)(A.F. Parlow National Hormone and Peptide Program,
Torrance, CA) or Melanotan II (MTII) (5 mg/kg)(Tocris,
Ellisville, MO). Baseline body weight was measured and a known
amount of food was added to each cage. Body weight and food
intake were then measured 1, 2, 4, 8, and 24 hours post-injection.
Immunohistochemistry (IHC)
Five series of 25 mm coronal brain sections were generated from
each animal as described earlier [16]. Supplies were from Sigma-
Aldrich (St. Louis, MO) and the ABC Vectastain Elite kit from
Vector Laboratories (Burlingame, CA). The phospho-specific-
(Y705)-STAT3 rabbit antibody was from New England Biolabs
(Beverly, MA), the rabbit anti-POMC antibody was from Phoenix
Pharmaceuticals (Burlingame, CA) and the rabbit anti-b-endor-
phin antibody was a kind gift from Dr. Oline Ronnekleiv (Oregon
Health and Science University, Portland, OR). The biotinylated
donkey-anti-rabbit antibody was from Jackson Immunology
Research Laboratories (West Grove, PA). Fluorescent donkey
anti-rabbit immunoglobulin conjugates were from Molecular
Probes (Eugene, OR), and donkey serum was from Invitrogen
Life Technologies, Inc (Carlsbad, CA). POMC- and P-STAT3-
immunoreactivity was detected by 3,39-diaminobenzidine (DAB)
and b-endorphin by fluorescence.
Figure 10. Leptin-sensitivity in POMC-LepRb mice on HFD and LFD. A. Acute food intake after leptin (5 mg/kg, i.p.) or vehicle (PBS) in POMC-
LepRb and control mice on LFD. B. Body weight change (relative to preinjection weight) after leptin administration in POMC-LepRb and control mice
on LFD. C. Food intake after leptin in POMC-LepRb and control mice after 5 weeks on HFD. B. Body weight change after leptin in POMC-LepRb and
control mice after 5 weeks on HFD. N=4 POMC-LepRb and N=5 control mice per group. *=p,0.05; **=p,0.01; ns=not significant. Data are means
+/2 SEM.
doi:10.1371/journal.pone.0030485.g010
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phosphorylation in arcuate neurons
Mice that were maintained on a LFD or HFD for 10 weeks
were injected i.p. with leptin (0.6 mg/kg (half-max dose); 30 min).
Brain sections (25 mm) were processed for P-STAT3 using the
ABC detection method [31]. The DAB reactions were terminated
in parallel for all sections before reaching maximal staining
intensity. Bright-field images (206 objective) from 5 matched
(rostral-caudal) hypothalamic sections from a 1:5 series in each
animal (N=3 LFD and N=3 HFD) were captured with digital
camera (AxioCam, Carl Zeiss, Thornwood, NY) mounted on a
Zeiss microscope (Axioscope2). P-STAT3 immunoreactive ARC
neurons were counted and nuclear-P-STAT3 staining in each cell
was quantified (grey-scale density) using ImageJ software (NIH)
[16] Cells within the median eminence and in non-arcuate nuclei
were excluded from these analyses. One brain hemisphere was
analyzed in each section.
Quantification of POMC polypeptide expression in POMC
cell bodies
Brain sections from the 10-week DIO study (above) were
processed for POMC IHC. The DAB reactions were stopped in
parallel for all sections before reaching maximal staining intensity,
which was determined by visual inspection during color develop-
ment. Brightfield images (206 objective) from 10–11 matched
(rostral-caudal) hypothalamic sections from a 1:5 series in each
animal (N=2 LFD and N=2 HFD) were captured as described
above. POMC-positive neurons throughout the mediobasal
Figure 11. Melanocortin (MTII)-sensitivity in POMC-LepRb mice on HFD and LFD. A. Acute food intake after MTII (5 mg/kg, i.p.) or vehicle
in POMC-LepRb and control mice on LFD. B. Body weight change (relative to preinjection weight) after MTII administration in POMC-LepRb and
control mice on LFD. C. Food intake after MTII in POMC-LepRb and control mice after 5 weeks on HFD. B. Body weight change after MTII in POMC-
LepRb and control mice after 5 weeks on HFD. N=4 POMC-LepRb and N=5 control mice per group. *=p,0.05; **=p,0.01; #=p,0.001. Data are
means +/2 SEM.
doi:10.1371/journal.pone.0030485.g011
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using ImageJ software. One brain hemisphere was analyzed in
each section.
Quantification of leptin-induced nuclear STAT3
phosphorylation in POMC neurons
Mice from a separate 16-week long DIO study were injected i.p.
with leptin (4 mg/kg; 30 min). Brain sections were subjected in
parallel to double IHC for P-STAT3 (DAB) and b-Endorphin
(fluorescence), as we have described earlier [16]. The DAB
reactions were stopped in parallel for all sections before reaching
maximal staining intensity as determined by visual inspection
during color development. Matching bright-field and fluorescent
images (206 objective) from matched hypothalamic sections
(N=9–11) from a 1:5 series in each animal were captured as
described above. POMC neurons were identified based on the
cytoplasmic localization of b-Endorphin. Nuclear P-STAT3
staining (grey-scale density) was then quantified with the ImageJ
software in each POMC neuron. One brain hemisphere was
analyzed in each section.
Pomc in situ hybridization
Free-floating brain sections were generated as described for
IHC (above). One 1:5 series from each animal (4 week-long DIO
study) were mounted on Superfrost Plus slides (Fisher, Hampton,
NH) and hybridized overnight with a 580 base long digoxigenin
(DIG)-labeled mouse pomc anti-sense RNA probe (0.6 mg/ml) at
60uC. All sections were washed twice in 0.2X SSC at 60uC,
blocked in PBS with 10% bovine serum, and reacted with anti-
DIG antibodies fused to alkaline phosphatase (Roche, Nutley, NJ)
(1:5000, 10% serum, 2 hours at room temperature). Sections were
washed and incubated with alkaline phosphatase substrate (NBT/
BCIP, Roche, Nutley, NJ) producing a color precipitate. The
reaction was stopped in parallel for all sections by EDTA before
reaching maximal staining intensity as determined by visual
inspection during color development. One hemisphere was
counted in all hypothalamic sections containing POMC neurons
(N=8–12 per animal). The number of POMC neurons counted in
one hemisphere of a complete 1:5 series was multiplied by 10
(265) for determination of the total number of hypothalamic
POMC neurons.
Body composition
Body composition analysis was carried out at 17 weeks of diets
using Echo-MRI (Echo Medical Systems, Houston, TX). Wet fat
pad weights of individual depots were measured immediately after
sacrifice after 19 weeks of diets.
Data analysis
Data sets were analyzed for statistical significance using two-
tailed Student’s T-test (Figs. 1A–F, 2, 3B–C, 4C–D, 5B–C, 6A,
9A–F) or using one-way ANOVA (Tukey’s posthoc analysis)
(Figs. 6B–C, 7A–D, 8A–B) or using two-way repeated measures
ANOVA (Bonferroni post-hoc analysis) (Figs. 6A, 10A–D, 11A–
D). All parameters are expressed as mean 6 SEM. A p-value of
,0.05 was accepted as being statistically significant.
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